Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Frederik Nevens

Showing results (121-130 of 344) with videos related to

Pageof 35
Sort By:
BMJ Open|May 11, 2019
Assessing testing rates for viral hepatitis B and C by general practitioners in Flanders, Belgium: a registry-based studyRob Bielen, Özgür M Koc, Dana Busschots, et al.
Inflammatory Bowel Diseases|April 25, 2006
CC-type chemokine receptor 5-Delta32 mutation protects against primary sclerosing cholangitisLiesbet Henckaerts, Johan Fevery, Werner Van Steenbergen, et al.
Journal of Clinical Virology : the Official Publication of the Pan American Society for Clinical Virology|December 11, 2007
HCV genotype 5: epidemiology and spread of an uncommon genotypeJannick Verbeeck, Hélène Peigue-Lafeuille, R Stefan Ross, et al.
Hepatology (Baltimore, Md.)|October 21, 2009
Role of beta3-adrenoceptors for intrahepatic resistance and portal hypertension in liver cirrhosisJonel Trebicka, Martin Hennenberg, Andrea Schulze Pröbsting, et al.
Ebiomedicine|September 26, 2020
Clinical relevance of plasma virome dynamics in liver transplant recipientsMarijn Thijssen, Frank Tacke, Leen Beller, et al.
Frontiers in Microbiology|May 25, 2023
Plasma virome dynamics in chronic hepatitis B virus infected patientsMarijn Thijssen, Frank Tacke, Lore Van Espen, et al.
Nature Reviews. Disease Primers|June 10, 2016
Acute-on-chronic liver failure in cirrhosisVicente Arroyo, Richard Moreau, Patrick S Kamath, et al.
Gut|December 17, 2010
Immune reactivity to β-tubulin isotype 5 and vesicular integral-membrane protein 36 in patients with autoimmune gastrointestinal disordersKatrijn Op De Beéck, Karolien Van den Bergh, Séverine Vermeire, et al.
Journal of Hepatology|July 5, 2014
Development and validation of a polycystic liver disease complaint-specific assessment (POLCA)Frederik Temmerman, Fabienne Dobbels, Thien Anh Ho, et al.
Transplant International : Official Journal of the European Society for Organ Transplantation|October 13, 2016
Center is an important indicator for choice of invasive therapy in polycystic liver diseaseHedwig M A D'Agnolo, Wietske Kievit, Kim N van Munster, et al.
Pageof 35

Showing results (121-130 of 344) with videos related to

Sort By:
Pageof 35
BMJ Open|May 11, 2019
Assessing testing rates for viral hepatitis B and C by general practitioners in Flanders, Belgium: a registry-based studyRob Bielen, Özgür M Koc, Dana Busschots, et al.
Inflammatory Bowel Diseases|April 25, 2006
CC-type chemokine receptor 5-Delta32 mutation protects against primary sclerosing cholangitisLiesbet Henckaerts, Johan Fevery, Werner Van Steenbergen, et al.
Journal of Clinical Virology : the Official Publication of the Pan American Society for Clinical Virology|December 11, 2007
HCV genotype 5: epidemiology and spread of an uncommon genotypeJannick Verbeeck, Hélène Peigue-Lafeuille, R Stefan Ross, et al.
Hepatology (Baltimore, Md.)|October 21, 2009
Role of beta3-adrenoceptors for intrahepatic resistance and portal hypertension in liver cirrhosisJonel Trebicka, Martin Hennenberg, Andrea Schulze Pröbsting, et al.
Ebiomedicine|September 26, 2020
Clinical relevance of plasma virome dynamics in liver transplant recipientsMarijn Thijssen, Frank Tacke, Leen Beller, et al.
Frontiers in Microbiology|May 25, 2023
Plasma virome dynamics in chronic hepatitis B virus infected patientsMarijn Thijssen, Frank Tacke, Lore Van Espen, et al.
Nature Reviews. Disease Primers|June 10, 2016
Acute-on-chronic liver failure in cirrhosisVicente Arroyo, Richard Moreau, Patrick S Kamath, et al.
Gut|December 17, 2010
Immune reactivity to β-tubulin isotype 5 and vesicular integral-membrane protein 36 in patients with autoimmune gastrointestinal disordersKatrijn Op De Beéck, Karolien Van den Bergh, Séverine Vermeire, et al.
Journal of Hepatology|July 5, 2014
Development and validation of a polycystic liver disease complaint-specific assessment (POLCA)Frederik Temmerman, Fabienne Dobbels, Thien Anh Ho, et al.
Transplant International : Official Journal of the European Society for Organ Transplantation|October 13, 2016
Center is an important indicator for choice of invasive therapy in polycystic liver diseaseHedwig M A D'Agnolo, Wietske Kievit, Kim N van Munster, et al.
Pageof 35